349 related articles for article (PubMed ID: 27784849)
1. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis.
Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K
J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849
[TBL] [Abstract][Full Text] [Related]
2. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
[TBL] [Abstract][Full Text] [Related]
3. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study.
Kohagura K; Kochi M; Miyagi T; Kinjyo T; Maehara Y; Nagahama K; Sakima A; Iseki K; Ohya Y
Hypertens Res; 2013 Jan; 36(1):43-9. PubMed ID: 22951520
[TBL] [Abstract][Full Text] [Related]
4. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
[TBL] [Abstract][Full Text] [Related]
5. Impact of Uric Acid Levels on Kidney Disease Progression.
Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
[TBL] [Abstract][Full Text] [Related]
6. Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients.
Nacak H; van Diepen M; de Goeij MC; Rotmans JI; Dekker FW;
BMC Nephrol; 2014 Jun; 15():91. PubMed ID: 24939671
[TBL] [Abstract][Full Text] [Related]
7. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
Russo E; Drovandi S; Salvidio G; Verzola D; Esposito P; Garibotto G; Viazzi F
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2343-2350. PubMed ID: 32912790
[TBL] [Abstract][Full Text] [Related]
8. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
[TBL] [Abstract][Full Text] [Related]
9. Effects of uric acid on kidney function decline differ depending on baseline kidney function in type 2 diabetic patients.
Hanai K; Tauchi E; Nishiwaki Y; Mori T; Yokoyama Y; Uchigata Y; Babazono T
Nephrol Dial Transplant; 2019 Aug; 34(8):1328-1335. PubMed ID: 29860523
[TBL] [Abstract][Full Text] [Related]
10. Association between serum uric acid level and renal arteriolar hyalinization in individuals without chronic kidney disease.
Matsukuma Y; Masutani K; Tanaka S; Tsuchimoto A; Haruyama N; Okabe Y; Nakamura M; Tsuruya K; Kitazono T
Atherosclerosis; 2017 Nov; 266():121-127. PubMed ID: 29024864
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
[TBL] [Abstract][Full Text] [Related]
12. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
Jeon HJ; Oh J; Shin DH
PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
[TBL] [Abstract][Full Text] [Related]
13. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study.
Chang YH; Lei CC; Lin KC; Chang DM; Hsieh CH; Lee YJ
Diabetes Metab Res Rev; 2016 Sep; 32(6):557-64. PubMed ID: 26590369
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
[TBL] [Abstract][Full Text] [Related]
16. Serum uric acid and the incidence of CKD and hypertension.
Kuriyama S; Maruyama Y; Nishio S; Takahashi Y; Kidoguchi S; Kobayashi C; Takahashi D; Sugano N; Hosoya T; Yokoo T
Clin Exp Nephrol; 2015 Dec; 19(6):1127-34. PubMed ID: 25967597
[TBL] [Abstract][Full Text] [Related]
17. Is increased uric acid a risk factor or a defensive response? The Campania Salute Network.
Mancusi C; Izzo R; Ferrara LA; Rozza F; Losi MA; Canciello G; Pepe M; de Luca N; Trimarco B; de Simone G
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):839-846. PubMed ID: 29898822
[TBL] [Abstract][Full Text] [Related]
18. Uric acid contributes to glomerular filtration rate deterioration in renal transplantation.
Kim KM; Kim SS; Yun S; Lee MS; Han DJ; Yang WS; Park JS; Park SK
Nephron Clin Pract; 2011; 118(2):c136-42. PubMed ID: 21150221
[TBL] [Abstract][Full Text] [Related]
19. Augmented Association Between Blood Pressure and Proteinuria in Hyperuricemic Patients With Nonnephrotic Chronic Kidney Disease.
Kohagura K; Kochi M; Miyagi T; Zamami R; Nagahama K; Yonemoto K; Ohya Y
Am J Hypertens; 2018 Mar; 31(4):480-485. PubMed ID: 28927237
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
